A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.

Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...

Health officials are urging older adults to get vaccinated against respiratory syncytial virus (RSV). NHS England announced ...

and respiratory syncytial virus (in layman’s terms: pretty much a cold). After that, I found myself down the rabbit’s hole. Apparently on the rise, Boots have launched a private RSV ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Respiratory syncytial virus (RSV) (Fig. 1) causes a spectrum of respiratory illnesses in infants and young children that may lead to hospitalisations and a substantial number of outpatient visits ...

As cold and flu season continues in Vermont, UVMMC is urging families to get their newborns and infants preventatively ...

Therapeutics Market Growth is Driven by Increased Awareness of RSV’s Health Risks and The Development of Advanced Treatment Options.Pune, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Respiratory Syncytial Virus ...

Respiratory syncytial virus (RSV) infections are the leading cause of viral death in infants, although RSV-related mortality has decreased since the development and approval of prophylactic ...